Miss Emma Swift
Teams and roles for Emma Swift
Research student
Research Assistant
Publication
2025
- Lovatt, C. et al. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23 (10), pp.3319-3326. (10.1016/j.jtha.2025.06.006)
- Swift, E. 2025. Novel strategies for developing tumour selective virotherapies. PhD Thesis , Cardiff University.
- Swift, E. A. and Parker, A. L. 2025. Adenoviral vector targeting. In: Curiel, D. T. and Parker, A. L. eds. Adenoviral Vectors for Gene Therapy. Elsevier. , pp.365-401. (10.1016/B978-0-323-89821-8.00017-6)
2022
- Swift, E. A. , Pollard, S. M. and Parker, A. L. 2022. Engineering cancer selective virotherapies: are the pieces of the puzzle falling into place?. Human Gene Therapy 33 (21-22)(10.1089/hum.2022.178)
Articles
- Lovatt, C. et al. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23 (10), pp.3319-3326. (10.1016/j.jtha.2025.06.006)
- Swift, E. A. , Pollard, S. M. and Parker, A. L. 2022. Engineering cancer selective virotherapies: are the pieces of the puzzle falling into place?. Human Gene Therapy 33 (21-22)(10.1089/hum.2022.178)
Book sections
- Swift, E. A. and Parker, A. L. 2025. Adenoviral vector targeting. In: Curiel, D. T. and Parker, A. L. eds. Adenoviral Vectors for Gene Therapy. Elsevier. , pp.365-401. (10.1016/B978-0-323-89821-8.00017-6)
Thesis
- Swift, E. 2025. Novel strategies for developing tumour selective virotherapies. PhD Thesis , Cardiff University.